265 related articles for article (PubMed ID: 28970488)
1. Single-cell analysis reveals sexually dimorphic repertoires of Interferon-γ and IL-17A producing T cells in salivary glands of Sjögren's syndrome mice.
Wanchoo A; Voigt A; Sukumaran S; Stewart CM; Bhattacharya I; Nguyen CQ
Sci Rep; 2017 Oct; 7(1):12512. PubMed ID: 28970488
[TBL] [Abstract][Full Text] [Related]
2. Sexual dimorphic function of IL-17 in salivary gland dysfunction of the C57BL/6.NOD-Aec1Aec2 model of Sjögren's syndrome.
Voigt A; Esfandiary L; Wanchoo A; Glenton P; Donate A; Craft WF; Craft SL; Nguyen CQ
Sci Rep; 2016 Dec; 6():38717. PubMed ID: 27958291
[TBL] [Abstract][Full Text] [Related]
3. Detection of IFN-γ+IL-17+ cells in salivary glands of patients with Sjögren's syndrome and Mikulicz's disease: Potential role of Th17•Th1 in the pathogenesis of autoimmune diseases.
Nanke Y; Kobashigawa T; Yago T; Kawamoto M; Yamanaka H; Kotake S
Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(5):473-477. PubMed ID: 27795505
[TBL] [Abstract][Full Text] [Related]
4. Unique glandular ex-vivo Th1 and Th17 receptor motifs in Sjögren's syndrome patients using single-cell analysis.
Voigt A; Bohn K; Sukumaran S; Stewart CM; Bhattacharya I; Nguyen CQ
Clin Immunol; 2018 Jul; 192():58-67. PubMed ID: 29679709
[TBL] [Abstract][Full Text] [Related]
5. Innate immune signaling induces interleukin-7 production from salivary gland cells and accelerates the development of primary Sjögren's syndrome in a mouse model.
Jin JO; Shinohara Y; Yu Q
PLoS One; 2013; 8(10):e77605. PubMed ID: 24147035
[TBL] [Abstract][Full Text] [Related]
6. Smad4 in T cells plays a protective role in the development of autoimmune Sjögren's syndrome in the nonobese diabetic mouse.
Kim D; Kim JY; Jun HS
Oncotarget; 2016 Dec; 7(49):80298-80312. PubMed ID: 27880731
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-36α axis is modulated in patients with primary Sjögren's syndrome.
Ciccia F; Accardo-Palumbo A; Alessandro R; Alessandri C; Priori R; Guggino G; Raimondo S; Carubbi F; Valesini G; Giacomelli R; Rizzo A; Triolo G
Clin Exp Immunol; 2015 Aug; 181(2):230-8. PubMed ID: 25902739
[TBL] [Abstract][Full Text] [Related]
8. Impaired Interleukin-27-Mediated Control of CD4+ T Cell Function Impact on Ectopic Lymphoid Structure Formation in Patients With Sjögren's Syndrome.
Lucchesi D; Coleby R; Pontarini E; Prediletto E; Rivellese F; Hill DG; Derrac Soria A; Jones SA; Humphreys IR; Sutcliffe N; Tappuni AR; Pitzalis C; Jones GW; Bombardieri M
Arthritis Rheumatol; 2020 Sep; 72(9):1559-1570. PubMed ID: 32307922
[TBL] [Abstract][Full Text] [Related]
9. Pathogenic effect of interleukin-17A in induction of Sjögren's syndrome-like disease using adenovirus-mediated gene transfer.
Nguyen CQ; Yin H; Lee BH; Carcamo WC; Chiorini JA; Peck AB
Arthritis Res Ther; 2010; 12(6):R220. PubMed ID: 21182786
[TBL] [Abstract][Full Text] [Related]
10. Development of Sjogren's syndrome in nonobese diabetic-derived autoimmune-prone C57BL/6.NOD-Aec1Aec2 mice is dependent on complement component-3.
Nguyen CQ; Kim H; Cornelius JG; Peck AB
J Immunol; 2007 Aug; 179(4):2318-29. PubMed ID: 17675493
[TBL] [Abstract][Full Text] [Related]
11. Fingolimod reduces salivary infiltrates and increases salivary secretion in a murine Sjögren's model.
Cohen PL; McCulloch A
J Autoimmun; 2020 Dec; 115():102549. PubMed ID: 33059968
[TBL] [Abstract][Full Text] [Related]
12. Interleukin (IL)-17-producing pathogenic T lymphocytes co-express CD20 and are depleted by rituximab in primary Sjögren's syndrome: a pilot study.
Alunno A; Carubbi F; Bistoni O; Caterbi S; Bartoloni E; Di Benedetto P; Cipriani P; Giacomelli R; Gerli R
Clin Exp Immunol; 2016 Jun; 184(3):284-92. PubMed ID: 26814615
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory caspases are critical for enhanced cell death in the target tissue of Sjögren's syndrome before disease onset.
Bulosan M; Pauley KM; Yo K; Chan EK; Katz J; Peck AB; Cha S
Immunol Cell Biol; 2009 Jan; 87(1):81-90. PubMed ID: 18936772
[TBL] [Abstract][Full Text] [Related]
14. Th17 cells in primary Sjögren's syndrome: Pathogenicity and plasticity.
Verstappen GM; Corneth OBJ; Bootsma H; Kroese FGM
J Autoimmun; 2018 Feb; 87():16-25. PubMed ID: 29191572
[TBL] [Abstract][Full Text] [Related]
15. The Th1/Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjogren's syndrome.
Mitsias DI; Tzioufas AG; Veiopoulou C; Zintzaras E; Tassios IK; Kogopoulou O; Moutsopoulos HM; Thyphronitis G
Clin Exp Immunol; 2002 Jun; 128(3):562-8. PubMed ID: 12067313
[TBL] [Abstract][Full Text] [Related]
16. Anti-120-kDa alpha-fodrin immune response with Th1-cytokine profile in the NOD mouse model of Sjögren's syndrome.
Yanagi K; Ishimaru N; Haneji N; Saegusa K; Saito I; Hayashi Y
Eur J Immunol; 1998 Oct; 28(10):3336-45. PubMed ID: 9808203
[TBL] [Abstract][Full Text] [Related]
17. Common T cell receptor clonotype in lacrimal glands and labial salivary glands from patients with Sjögren's syndrome.
Matsumoto I; Tsubota K; Satake Y; Kita Y; Matsumura R; Murata H; Namekawa T; Nishioka K; Iwamoto I; Saitoh Y; Sumida T
J Clin Invest; 1996 Apr; 97(8):1969-77. PubMed ID: 8621782
[TBL] [Abstract][Full Text] [Related]
18. Invariant NKT cells are expanded in peripheral blood but are undetectable in salivary glands of patients with primary Sjögren's syndrome.
Guggino G; Ciccia F; Raimondo S; Giardina G; Alessandro R; Dieli F; Sireci G; Triolo G
Clin Exp Rheumatol; 2016; 34(1):25-31. PubMed ID: 26633038
[TBL] [Abstract][Full Text] [Related]
19. Single cell analysis of T cells infiltrating labial salivary glands from patients with Sjögren's syndrome.
Matsumoto I; Okada S; Kuroda K; Iwamoto I; Saito Y; Tokuhisa T; Nishioka K; Sumida T
Int J Mol Med; 1999 Nov; 4(5):519-27. PubMed ID: 10534575
[TBL] [Abstract][Full Text] [Related]
20. Early Covert Appearance of Marginal Zone B Cells in Salivary Glands of Sjögren's Syndrome-Susceptible Mice: Initiators of Subsequent Overt Clinical Disease.
Peck AB; Nguyen CQ; Ambrus J
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
